Veridex, LLC, a Johnson & Johnson company, is an organization dedicated to providing physicians and patients with high-value in vitro diagnostic oncology products.Veridex’s products will significantly benefit patients through earlier disease detection, and will enable personalized strategies to improve patient management and outcomes.

Hill's Pet Nutrition, Inc. provides pet food products and pet care services. It offers products to the breeders, veterinarians, and pet supply retailers. The company was founded by Mark L. Morris in 1939 and is headquartered in Topeka, KS.

Genomatix Software GmbH, a computational biology company, provides software, databases, and services for understanding gene regulation at the molecular level representing a central part of systems biology. The company combines sequence analysis, functional promoter analysis, proprietary genome annotation, promoter sequence databases, comparative genomics, scientific literature data mining, pathway databases, biological network databases, pathway analysis, network analysis, and expression profiling into working solutions and pipelines. It offers Genomatix Genome Analyzer, which analyzes next generation sequencing (NGS) data; Genomatix Mining Station that provides genome positioning, splice analysis, and genotyping using the data from NGS experiment; GenomatixSuite, which is used for chromatin IP, microarray analysis, genome annotation, knowledge mining, and sequence analysis; and Genomatix tools for sequence statistics, extraction, and formatting. The company also provides collaborative and contract research, including gene regulation, regulatory pathways, or microarray analysis; and promoter and microarray analysis training and education services. Genomatix offers its products through distributors in Tokyo, Japan; San Jose, California; and Melbourne, Australia. It has a strategic partnership with Molecular Connections. The company was founded in 1997 and is based in Munich, Germany with a seat of business in Ann Arbor, Michigan.

Korea Hydro & Nuclear Power Co. Ltd. produces and supplies electric power. It operates nuclear plants in Busan, Ulsan, North-Gyeongsang, and North-Jeonla and renewable energy generation facilities. The company was founded on April 2, 2001 and is headquartered in Seoul, South Korea.

Oncotech, Inc. provides molecular oncology testing services. The firm's services improve the survival and quality of life of cancer patients through its molecular oncology testing services. Oncotech provides its testing services to hospitals in the US. The company was founded in 1985 and is headquartered in Tustin, CA.

Berkeley Nanjing Medical Research Co., Ltd., established on 2018-11-26, Business scope includes licensed projects:Disinfection equipment sales(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Specialty Chemicals Sales(Free of Hazardous Chemicals);New material technology research and development;gas,Liquid separation and purification equipment sales;Sales of Class II Medical Devices;software development;Environmental Consulting Services;rental service(Does not include publication rental);Technology Import and Export(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Helix BioMedix is specialty dermatology and consumer products skin health company developing bioactive peptides for uses across a wide range of markets. Our mission is to enrich clinical practice and the patient/consumer experience by developing topically-applied products which offer the health, beauty and safety benefits of our advanced bioactive small molecule technology. Our vision is to be recognized as the world leader in the identification, qualification and commercialization of natural and synthetic peptides.

Pacific Edge Ltd. engages in the discovery and commercialization of diagnostic and prognostic technology for the early detection and monitoring of cancer. It operates in the Commercial and Research segments. The Commercial segment involves the sales, marketing, laboratory, and support to run the commercial businesses worldwide. The Research segment engages in the research and development of diagnostic and prognostic products for human cancer. The company was founded on February 27, 2001 and is headquartered in Dunedin, New Zealand.

Affymetrix, Inc. was an American company that manufactured DNA microarrays; it was based in Santa Clara, California, United States. The company was acquired by Thermo Fisher Scientific in March 2016. The company was founded by Stephen Fodor in 1992. It began as a unit in Affymax N.V. in 1991 by Fodor's group, which had in the late 1980s developed methods for fabricating DNA microarrays, called "GeneChip" according to the Affymetrix trademark, using semiconductor manufacturing techniques. The company's first product, an HIV genotyping GeneChip, was introduced in 1994 and the company went public in 1996. As a result of its pioneering work and the ensuing popularity of microarray products, Affymetrix derived significant benefit from its patent portfolio in this area.

Part of Gerresheimer AG, Gerresheimer Regensburg GmbH is a German company located in Regensburg. The firm manufactures plastic products. Dietmar Siemssen is the current CEO of the firm.\nThe company says this about itself: Gerresheimer Regensburg GmbH engages in the production and distribution of medical devices and primary packaging material for drugs and medicinal products made of plastics.

Hankook Cosmetics Manufacturing Co., Ltd. engages in the production and development of cosmetics. It operates through the following business divisions: Base and Make Up. The Base business provides skin, hair and functional care lines. The Make Up business offers make-up base, foundation, concealer, bb cream, mascara, eyeliner and other products. The company was founded on March 21, 1962 and is headquartered in Seoul, South Korea.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Cell2in, Inc. is a private company headquartered in Jongro-gu, the South Korea. The firm operates cell therapy.

Front Range Biosciences, Inc. operates as a biotechnology company. It offers clean stock hemp plants, feminized hemp seeds and nursery services. The company was founded by Jonathan Vaught, Christopher Zalewski and Nicholas Hofmeister in April 2015 and is headquartered in Lafayette, CO.

Molecular Stethoscope, Inc. provides molecular diagnostics services. It offers novel blood-based early detection and disease monitoring tests to detect liver, coronary artery, inflammatory, neurodegenerative, coronary artery, autoimmune and inflammatory diseases. The company was founded by Stephen D. Phil Quake and Eric J. Topol on September 1, 2015 and is headquartered in San Diego, CA.

DxTerity Diagnostics is focused on simplifying genomic testing -- bringing the power of personalized medicine to routine medical care. The DxTerity technology, DxDirectTM, is a simple, fast and affordable technique for analysis of complex gene signatures. DxDirectTM combines a robust chemical ligation process, NEATTM , and a unique sample stabilization system, DxCollectTM. This enable direct from whole blood or tissue sample multiplex gene expression testing without many of the constraints that exist today. Testing which once could only be done by a sophisticated research lab, or highly specialized and high skilled area within a clinical lab, can now be performed reliably in a routine manner by lab technicians and clinicians, all with the same level of quality. Specialties-Molecular Diagnostics, Oncology, Immune Response